Arcadia Biosciences RKDA Income Statement (2014-2026)

NASDAQ RKDA
$0.28 -0.03 (-8.86%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Arcadia Biosciences Quarterly Income Statement

Periods 49 quarters
Latest Jun 2026

Arcadia Biosciences reported revenue of $1.44M and net income of -$0.50M for the quarter ended Jun 2026, up 20.3% year over year. This income statement covers 49 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue
1.41M2.38M2.17M3.22M3.86M1.57M0.74M1.23M1.30M1.30M0.78M0.99M1.31M1.54M1.22M1.20M1.46M1.30M0.90M1.44M
Cost of RevenueCost of Rev
1.59M2.51M3.75M3.46M3.45M1.13M0.90M0.69M0.65M0.82M0.18M0.47M0.63M1.03M0.83M0.68M0.82M0.88M0.71M0.81M
Gross Profit
-0.18M-0.14M-1.58M-0.24M0.41M0.44M-0.16M0.54M0.65M0.48M0.60M0.52M0.67M0.51M0.39M0.52M0.63M0.42M0.19M0.63M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
0.01M
Research & DevelopmentR&D
1.13M1.04M0.56M0.40M0.36M0.26M0.50M0.36M0.03M0.01M0.01M0.01M0.01M0.02M0.01M0.01M
Selling, General & AdministrativeSG&A
6.37M6.31M6.21M4.35M4.65M4.18M3.63M4.07M2.07M1.86M1.70M2.06M2.68M2.24M2.65M1.74M2.12M1.57M1.57M1.13M
Restructuring CostsRestructuring
0.40M0.35M
Other Operating ExpensesOther Opex
-0.07M-0.03M-0.04M0.49M-0.04M-0.28M-0.31M-0.16M1.00M1.00M-0.29M0.28M
Operating ExpensesOpex
9.09M11.09M15.97M7.84M7.64M5.56M5.40M5.10M2.75M2.69M1.97M2.58M-0.67M3.30M3.50M0.67M1.96M2.45M2.28M1.94M
Operating IncomeOp. Inc
-7.68M-8.71M-13.80M-4.62M-3.78M-3.99M-4.66M-3.87M-1.45M-1.40M-1.19M-1.59M1.98M-1.76M-2.28M0.53M-0.50M-1.15M-1.38M-0.50M
EBIT
-7.68M-8.71M-13.80M-4.62M-3.78M-3.99M-4.66M-3.87M-1.45M-1.40M-1.19M-1.59M1.98M-1.76M-2.28M0.53M-0.50M-1.15M-1.38M-0.50M
Non-operating items
Non Operating Interest Expenses
0.00M0.01M-0.00M0.00M
Non Operating Investment IncomeNon-Op. Investment Inc.
-0.48M0.33M1.14M0.02M0.03M4.00M0.75M
Other Non Operating IncomeOther Non Op Inc.
2.76M-0.01M-0.10M0.01M-0.04M0.04M-0.00M0.03M-0.01M0.02M0.01M0.00M0.15M0.01M-0.14M1.07M1.70M-0.46M-2.78M
Net income details
EBT
-7.68M-8.73M-13.80M-4.62M-3.78M-2.29M-3.17M-3.87M3.16M-0.64M-0.45M-1.59M1.85M-1.18M-4.03M0.53M-0.50M-1.15M-1.38M-0.50M
Tax ProvisionsTaxes
0.00M0.00M0.00M0.01M0.00M0.01M0.01M
Profit After TaxPAT
-7.68M-8.73M-13.80M-4.62M-3.78M-2.29M-3.18M-3.87M3.15M-0.64M-0.45M-1.59M1.85M-1.18M-4.04M0.53M-0.50M-1.15M-1.38M-0.50M
Equity Income
Income from Non-Controlling InterestsInc. Minority
-0.16M-0.66M-0.30M-0.12M-0.02M-0.01M-0.08M-0.01M
Income from Continuing OperationsIncome (Continuing)
-7.68M-8.73M-13.80M-4.62M-3.78M-2.29M-3.18M-9.20M3.15M-0.64M-0.45M-0.95M1.85M-1.18M-4.04M2.60M-4.46M0.86M-1.34M-0.50M
Income from Discontinued OperationsIncome (Discontinued)
-0.59M-1.15M-0.18M-2.34M-0.08M-0.23M-1.48M-0.79M-0.43M-0.03M
Consolidated Net IncomeConsol Net Inc.
-5.42M-2.84M-9.56M-4.61M-3.80M-2.88M-4.33M-9.38M0.82M-2.57M-2.87M-2.42M1.06M-1.61M-4.04M2.60M-4.46M0.86M-1.34M-0.50M
Income towards Parent CompanyParent Net Inc
-5.26M-2.17M-9.28M-4.49M-3.78M-2.87M-4.24M-9.38M0.82M-2.57M-2.85M-2.42M1.06M-1.61M-4.06M2.60M-4.46M0.86M-1.34M-6.27M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-5.26M-2.17M-9.28M-4.49M-3.78M-2.87M-4.24M-9.38M0.82M-2.57M-2.85M-2.42M1.06M-1.61M-4.06M2.60M-4.46M0.86M-1.34M-6.27M
Additional items
EPS (Basic)
-0.24-0.10-0.44-0.20-0.17-0.12-7.08-10.860.61-1.89-2.31-1.780.78-1.18-2.981.90-3.260.63-0.98-2.09
EPS (Diluted)
-0.24-0.10-17.45-8.09-6.81-4.67-7.08-10.860.61-1.89-2.31-1.780.78-1.18-2.981.90-3.260.62-0.98-2.09
Shares Outstanding
21.75M22.18M21.28M22.19M22.19M24.55M0.60M0.86M1.36M1.36M1.24M1.36M1.36M1.36M1.36M1.37M1.37M1.37M1.37M2.99M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
21.75M22.18M0.53M0.55M0.55M0.61M0.60M0.86M1.36M1.36M1.24M1.36M1.36M1.36M1.36M1.37M1.37M1.37M1.37M2.99M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
22.16M22.18M22.18M22.19M22.19M24.64M0.62M0.86M1.11M1.11M1.29M1.36M1.36M1.36M1.36M1.37M1.37M1.37M1.37M2.99M
EBITDA
-7.41M-8.41M-13.60M-4.46M-3.64M-3.90M-4.57M-3.80M-1.43M-1.31M-1.13M-1.54M2.01M-1.75M-2.26M0.54M-0.49M-1.15M-1.37M-0.50M
Interest ExpensesInt Expense
0.00M0.01M-0.00M0.00M
Tax Rate
0.03%

Arcadia Biosciences Income Statement API

Pull Arcadia Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RKDA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY